GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aethlon Medical Inc (FRA:EJU0) » Definitions » Debt-to-Asset

Aethlon Medical (FRA:EJU0) Debt-to-Asset : 0.10 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Aethlon Medical Debt-to-Asset?

Aethlon Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.26 Mil. Aethlon Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €0.67 Mil. Aethlon Medical's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was €9.57 Mil. Aethlon Medical's debt to asset for the quarter that ended in Dec. 2023 was 0.10.


Aethlon Medical Debt-to-Asset Historical Data

The historical data trend for Aethlon Medical's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aethlon Medical Debt-to-Asset Chart

Aethlon Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.01 - 0.04 0.07

Aethlon Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.07 0.08 0.10

Competitive Comparison of Aethlon Medical's Debt-to-Asset

For the Medical Devices subindustry, Aethlon Medical's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aethlon Medical's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aethlon Medical's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Aethlon Medical's Debt-to-Asset falls into.



Aethlon Medical Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Aethlon Medical's Debt-to-Asset for the fiscal year that ended in Mar. 2023 is calculated as

Aethlon Medical's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aethlon Medical  (FRA:EJU0) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Aethlon Medical Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Aethlon Medical's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Aethlon Medical (FRA:EJU0) Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Aethlon Medical (FRA:EJU0) Headlines

No Headlines